Narlumosbartmab Combined With Neoadjuvant Chemotherapy in Bone-derived Malignancies With Osteolytic Lesions and Multinucleated Giant Cells
Conditions
Malignant Bone Tumor
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Peking University People's Hospital, Beijing, Beijing Municipality, China
Study leads
Lu Xie, M.D.
Principal Investigator
Musculoskeletal Tumor Center of Peking University People's Hospital